Liver cirrhosis with marked thrombocytopenia and highly elevated serum thrombopoietin levels

Kiyoshi Kitano*, Shigetaka Shimodaira, Toshiro Ito, Naoaki Ichikawa, Hiroshi Kodaira, Yoichi Kohara, Mayumi Ueno, Tomoyuki Tahara, Takashi Kato, Fumihiro Ishida, Kendo Kiyosawa

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Three patients with liver cirrhosis (LC) and a bleeding tendency due to marked thrombocytopenia of less than 20 × 109/1 were admitted to our hospital for further examination. Bone marrow examination revealed megakaryocytic hypoplasia in all three patients. All patients exhibited amegakaryocytic thrombocytopenic purpura, myelodysplastic syndrome, or bone marrow hypoplasia. 111In-labeled platelet kinetic studies revealed decreased platelet production in all patients. Although serum thrombopoietin (sTPO) levels are usually within the normal level in patients with LC, the sTPO levels of our patients were about 10 times higher than the levels of normal subjects (1.22 ± 0.37 fmol/ml): 13.34, 16.79, and 10.46 fmol/ml, respectively. These sTPO data supported our findings of decreased megakaryopoiesis. Our findings suggest that examination of sTPO lev els is useful in determining the etiology of marked thrombocytopenia in LC patients.

Original languageEnglish
Pages (from-to)52-55
Number of pages4
JournalInternational Journal of Hematology
Issue number1
Publication statusPublished - 1999
Externally publishedYes


  • Liver cirrhosis
  • Platelet kinetics
  • Thrombocytopenia
  • Thrombopoietin

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Liver cirrhosis with marked thrombocytopenia and highly elevated serum thrombopoietin levels'. Together they form a unique fingerprint.

Cite this